Home › Funds › Deep Track Capital, LP › CRVS
Deep Track Capital, LP position in CRVS
CORVUS PHARMACEUTICALS INC · Health Care
Deep Track Capital, LP reported holding 2,491,939 shares of CRVS (CORVUS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$28.7M, representing 0.48% of its reported portfolio and ranking #47 among its reported holdings. Deep Track Capital, LP has disclosed CRVS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Deep Track Capital, LP's CRVS position evolved
Deep Track Capital, LP first disclosed a stake in CRVS in Q1 2026 at 2,491,539 shares (US$36.5M). The position peaked in Q2 2026 at 2,491,939 shares, worth US$37.2M. Across 3 filings, Deep Track Capital, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 2,491,939 shares valued at US$28.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 2.49M | $36.45M | New |
| Q2 2026 | 2.49M | $37.23M | Hold |
| Q3 2026 | 2.49M | $28.71M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRVS and 13F data
CRVS (CORVUS PHARMACEUTICALS INC) is a Health Care company. 62 other funds we track also report a position in CRVS — the largest reported positions include ORBIMED ADVISORS LLC (US$107.0M), PERCEPTIVE ADVISORS LLC (US$39.9M), ADAMS STREET PARTNERS LLC (US$37.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRVS
- ORBIMED ADVISORS LLC 7.17M sh · $107.05M · Q2 2026
- PERCEPTIVE ADVISORS LLC 2.67M sh · $39.85M · Q2 2026
- ADAMS STREET PARTNERS LLC 3.28M sh · $37.74M · Q3 2026
- Vivo Capital, LLC 2.81M sh · $32.32M · Q3 2026
- BRAIDWELL LP 2.13M sh · $31.77M · Q2 2026
- Foresite Capital Management VI LLC 1.83M sh · $27.36M · Q2 2026
- Boxer Capital Management, LLC 1.10M sh · $16.43M · Q2 2026
- Catalio Capital Management, LP 1.08M sh · $16.15M · Q2 2026
- DCF Advisers, LLC 641.50K sh · $7.39M · Q3 2026
- Nextech Invest Ltd. 450.00K sh · $6.72M · Q2 2026
- Blue Owl Capital Holdings LP 358.60K sh · $4.13M · Q3 2026
- Propel Bio Management, LLC 264.31K sh · $3.04M · Q3 2026
More on Deep Track Capital, LP
FAQ
How long has Deep Track Capital, LP held CRVS?
Deep Track Capital, LP has disclosed CRVS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Deep Track Capital, LP's current position in CRVS?
As of Q3 2026, Deep Track Capital, LP holds 2.49M shares of CRVS (CORVUS PHARMACEUTICALS INC), valued at $28.71M, representing 0.48% of its reported portfolio and ranking #47.
Has Deep Track Capital, LP been buying or selling CRVS?
In the latest 13F filing (Q3 2026), Deep Track Capital, LP held unchanged its position in CRVS. The position peaked in Q2 2026 at 2.49M shares.
Which other funds hold CRVS?
Other major institutional holders of CRVS include ORBIMED ADVISORS LLC, PERCEPTIVE ADVISORS LLC, ADAMS STREET PARTNERS LLC, among 62 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.